342 related articles for article (PubMed ID: 30515538)
1. Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.
Alamri H; Patterson NH; Yang E; Zoroquiain P; Lazaris A; Chaurand P; Metrakos P
Anal Bioanal Chem; 2019 Feb; 411(4):885-894. PubMed ID: 30515538
[TBL] [Abstract][Full Text] [Related]
2. Metabolic-associated fatty liver disease and lipoprotein metabolism.
Heeren J; Scheja L
Mol Metab; 2021 Aug; 50():101238. PubMed ID: 33892169
[TBL] [Abstract][Full Text] [Related]
3. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.
Rodríguez-Calvo R; Samino S; Girona J; Martínez-Micaelo N; Ràfols P; García-Altares M; Guaita-Esteruelas S; Junza A; Heras M; Yanes O; Correig X; Masana L
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899418
[TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
6. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
Hall Z; Bond NJ; Ashmore T; Sanders F; Ament Z; Wang X; Murray AJ; Bellafante E; Virtue S; Vidal-Puig A; Allison M; Davies SE; Koulman A; Vacca M; Griffin JL
Hepatology; 2017 Apr; 65(4):1165-1180. PubMed ID: 27863448
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy.
Minamikawa T; Ichimura-Shimizu M; Takanari H; Morimoto Y; Shiomi R; Tanioka H; Hase E; Yasui T; Tsuneyama K
Sci Rep; 2020 Oct; 10(1):18548. PubMed ID: 33122711
[TBL] [Abstract][Full Text] [Related]
8. Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity.
Ščupáková K; Soons Z; Ertaylan G; Pierzchalski KA; Eijkel GB; Ellis SR; Greve JW; Driessen A; Verheij J; De Kok TM; Olde Damink SWM; Rensen SS; Heeren RMA
Anal Chem; 2018 Apr; 90(8):5130-5138. PubMed ID: 29570976
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.
Vergani L
Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680
[TBL] [Abstract][Full Text] [Related]
11. Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in
Schiffrin M; Winkler C; Quignodon L; Naldi A; Trötzmüller M; Köfeler H; Henry H; Parini P; Desvergne B; Gilardi F
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576136
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
[TBL] [Abstract][Full Text] [Related]
13. Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.
Kawano Y; Nishiumi S; Saito M; Yano Y; Azuma T; Yoshida M
Curr Drug Targets; 2015; 16(12):1293-300. PubMed ID: 25850622
[TBL] [Abstract][Full Text] [Related]
14. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
Park H; Liu Y; Kim HS; Shin JH
Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
[TBL] [Abstract][Full Text] [Related]
15. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
Scorletti E; Byrne CD
Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
[TBL] [Abstract][Full Text] [Related]
17. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice.
Kochan K; Maslak E; Krafft C; Kostogrys R; Chlopicki S; Baranska M
J Biophotonics; 2015 Jul; 8(7):597-609. PubMed ID: 25346221
[TBL] [Abstract][Full Text] [Related]
18. A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD.
Ashworth WB; Davies NA; Bogle ID
PLoS Comput Biol; 2016 Sep; 12(9):e1005105. PubMed ID: 27632189
[TBL] [Abstract][Full Text] [Related]
19. LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.
Tanaka Y; Shimanaka Y; Caddeo A; Kubo T; Mao Y; Kubota T; Kubota N; Yamauchi T; Mancina RM; Baselli G; Luukkonen P; Pihlajamäki J; Yki-Järvinen H; Valenti L; Arai H; Romeo S; Kono N
Gut; 2021 Jan; 70(1):180-193. PubMed ID: 32253259
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]